Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

List of androgen esters

From Wikipedia, the free encyclopedia

Testosterone, the base androgen of most androgen esters.

This is alist ofandrogen esters, includingesters (as well asethers) ofnaturalandrogens liketestosterone anddihydrotestosterone (DHT) andsyntheticanabolic–androgenic steroids (AAS) likenandrolone (19-nortestosterone).

Esters of natural AAS

[edit]

Testosterone esters

[edit]

Marketed

[edit]

Many esters of testosterone have been marketed, including the following major esters:[1][2]

And the following less commonly used esters:[1][2]

Never marketed

[edit]

The following major testosterone ester has not been marketed:[1][2]

  • Testosterone buciclate (20 Aet-1, CDB-1781) – a very long-acting testosterone ester that was under development but ultimately did not reach the market[4][5]

And the following less commonly known testosterone esters have also not been marketed:[1][2]

Dihydrotestosterone esters

[edit]

Marketed

[edit]

Several esters ofdihydrotestosterone (DHT;androstanolone, stanolone) have also been marketed, including the following:[8][9]

Never marketed

[edit]

The following esters of DHT have not been marketed:[8][9]

Testifenon (chlorphenacyl DHT ester) is anitrogen mustardester of DHT that was developed as acytostatic antineoplastic agent but was never marketed.[10]

Esters of other natural AAS

[edit]

Marketed

[edit]

The following esters of other natural AAS have been marketed:

Never marketed

[edit]

And the following have not been marketed:

Sturamustine is anitrosoureaester ofdehydroepiandrosterone (DHEA) that was developed as acytostatic antineoplastic agent but was never marketed.[12][13]

Ethers of natural AAS

[edit]

Marketed

[edit]

Although not esters, the following ethers of natural AAS have been marketed as well:

Never marketed

[edit]

And the following have not been marketed:

Esters of synthetic AAS

[edit]

Methandriol esters

[edit]

Marketed

[edit]

Never marketed

[edit]

Nandrolone esters

[edit]

Marketed

[edit]

Many esters of the synthetic AASnandrolone (19-nortestosterone) have been marketed, including the following major esters:[14][15][16]

And the following less commonly used esters:[14][15][16]

Never marketed

[edit]

The following nandrolone esters exist but were never marketed:

LS-1727 is anitrosocarbamateester of nandrolone that was developed as acytostatic antineoplastic agent but was never marketed.[19]

Trenbolone esters

[edit]

Marketed

[edit]

A few esters of the synthetic AAStrenbolone have been marketed, including the following esters:

Never marketed

[edit]

The following trenbolone esters exist but were never marketed:

Esters of other synthetic AAS

[edit]

Marketed

[edit]

Many esters of other synthetic AAS have been marketed as well, including the following:

Never marketed

[edit]

Whereas the following have not been marketed:

Ethers of synthetic AAS

[edit]

Marketed

[edit]

Although not esters, the following ethers of synthetic AAS have been marketed as well:

Never marketed

[edit]

And the following have not been marketed:

See also

[edit]

References

[edit]
  1. ^abcdIndex Nominum 2000: International Drug Directory. Taylor & Francis US. 2000.ISBN 978-3-88763-075-1. Retrieved29 May 2012.
  2. ^abcdefgJ. Elks (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 642–.ISBN 978-1-4757-2085-3.
  3. ^William Llewellyn (2011).Anabolics. Molecular Nutrition Llc. pp. 437–.ISBN 978-0-9828280-1-4.
  4. ^E. Nieschlag; H. M. Behre (1 April 2004).Testosterone: Action, Deficiency, Substitution. Cambridge University Press. pp. 692–.ISBN 978-1-139-45221-2.
  5. ^Shalender Bhasin (13 February 1996).Pharmacology, Biology, and Clinical Applications of Androgens: Current Status and Future Prospects. John Wiley & Sons. pp. 471–.ISBN 978-0-471-13320-9.
  6. ^"R&D Research".www.evestra.com. Archived fromthe original on 2017-09-29.
  7. ^Ahmed G, Elger W, Meece F, Nair HB, Schneider B, Wyrwa R, Nickisch K (October 2017). "A prodrug design for improved oral absorption and reduced hepatic interaction".Bioorg. Med. Chem.25 (20):5569–5575.doi:10.1016/j.bmc.2017.08.027.PMID 28886996.
  8. ^abJ. Elks (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 640–.ISBN 978-1-4757-2085-3.
  9. ^abI.K. Morton; Judith M. Hall (6 December 2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 261–.ISBN 978-94-011-4439-1.
  10. ^Lagova ND, Sof'ina ZP, Shkodinskaia EN, Kurdiumova KN, Valueva IM (1988). "[The antineoplastic activity of testiphenon]".Vopr Onkol (in Russian).34 (11):1363–8.PMID 3201773.
  11. ^George W.A Milne (8 May 2018).Drugs: Synonyms and Properties: Synonyms and Properties. Taylor & Francis. pp. 67–.ISBN 978-1-351-78989-9.
  12. ^J. Elks (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 1122.ISBN 978-1-4757-2085-3.
  13. ^Chavis C, de Gourcy C, Borgna JL, Imbach JL (1982). "New steroidal nitrosoureas".Steroids.39 (2):129–47.doi:10.1016/0039-128x(82)90081-2.PMID 7071885.S2CID 21042994.
  14. ^abJ. Elks (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 660–.ISBN 978-1-4757-2085-3.
  15. ^abIndex Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 716–717.ISBN 978-3-88763-075-1.
  16. ^abI.K. Morton; Judith M. Hall (6 December 2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media.ISBN 978-94-011-4439-1.
  17. ^Lerner, Leonard J.; Holthaus, Fred J.; Thompson, Charles R. (1959). "A myotrophic agent and gonadotrophin inhibitor, 19-nortestosterone-17-benzoate".Endocrinology.64 (6):1010–1016.doi:10.1210/endo-64-6-1010.ISSN 0013-7227.PMID 13652918.
  18. ^Boschann, H. -W. (1955). "Cytologische Untersuchungen über die Wirkung von Androgenen am atrophischen Vaginalepithel in Abhängigkeit von Dosierung und Applikationsart".Archiv für Gynäkologie.187 (1):39–64.doi:10.1007/BF00985845.ISSN 0003-9128.PMID 13303168.S2CID 30443548.
  19. ^Hartley-Asp B, Wilkinson R, Venitt S, Harrap KR (1981). "Studies on the mechanism of action of LS 1727, a nitrosocarbamate of 19-nortestosterone".Acta Pharmacol Toxicol (Copenh).48 (2):129–38.doi:10.1111/j.1600-0773.1981.tb01598.x.PMID 6167141.
Topics
Esters
Related
Androgens
(incl.AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptoragonists
Progonadotropins
Antiandrogens
ARTooltip Androgen receptorantagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
ARTooltip Androgen receptor
Agonists
SARMsTooltip Selective androgen receptor modulator
Antagonists
GPRC6A
Agonists
Retrieved from "https://en.wikipedia.org/w/index.php?title=List_of_androgen_esters&oldid=1303035722"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp